Collegium Pharmaceutical, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | 82.9% | -1,067.0% | -1,062.5% |
| Jun 2017 | 83.8% | -597.1% | -593.3% |
| Sep 2017 | 95.4% | -112.4% | -111.0% |
| Dec 2017 | 89.9% | -162.9% | -161.2% |
| Mar 2018 | 32.4% | -20.7% | -29.3% |
| Jun 2018 | 35.9% | -10.0% | -17.9% |
| Sep 2018 | 34.4% | -15.9% | -23.5% |
| Dec 2018 | 59.5% | 15.0% | 12.4% |
| Mar 2019 | 34.0% | -13.4% | -13.0% |
| Jun 2019 | 35.2% | -6.7% | -6.3% |
| Sep 2019 | 35.9% | -8.7% | -8.4% |
| Dec 2019 | 33.8% | -3.2% | -3.0% |
| Mar 2020 | 51.0% | 6.6% | 0.6% |
| Jun 2020 | 62.0% | 21.2% | 10.3% |
| Sep 2020 | 60.9% | 24.8% | 14.3% |
| Dec 2020 | 58.1% | 19.7% | 9.1% |
| Mar 2021 | 63.4% | 24.2% | 17.9% |
| Jun 2021 | 60.6% | 19.8% | 87.8% |
| Sep 2021 | 58.5% | 17.9% | 10.2% |
| Dec 2021 | -4.9% | -124.7% | -91.5% |
| Mar 2022 | 57.9% | -12.0% | -15.6% |
| Jun 2022 | 42.4% | 9.0% | -4.2% |
| Sep 2022 | 46.3% | 16.1% | 0.4% |
| Dec 2022 | 38.4% | 9.1% | -5.6% |
| Mar 2023 | 53.5% | 17.0% | -12.0% |
| Jun 2023 | 54.5% | 26.3% | 9.6% |
| Sep 2023 | 58.7% | 32.9% | 15.1% |
| Dec 2023 | 63.2% | 41.2% | 21.3% |
| Mar 2024 | 63.1% | 34.1% | 19.1% |
| Jun 2024 | 62.5% | 32.7% | 13.5% |
| Sep 2024 | 60.8% | 21.9% | 5.9% |
| Dec 2024 | 54.0% | 20.9% | 6.9% |
| Mar 2025 | 54.8% | 12.2% | 1.4% |
| Jun 2025 | 57.7% | 18.7% | 6.4% |
| Sep 2025 | 61.7% | 29.7% | 15.0% |
| Dec 2025 | 62.5% | 29.6% | 8.3% |
| Mar 2026 | 60.6% | 16.0% | 7.5% |
| Jun 2026 | 55.2% | 1.9% | -7.5% |